Company Filing History:
1 out of 832,912 Years Active: 2011
Title: Innovations by Alfred Hartman
Introduction
Alfred Hartman is a notable inventor based in Erlenbach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize fetal hemoglobin and bacterial endotoxin. His innovative work aims to enhance immunomodulation and offers potential therapeutic applications.
Latest Patents
Alfred Hartman holds 1 patent for his invention titled "Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components." This patent describes a pharmaceutical composition that represents a novel immunomodulating principle. The composition includes bacterial endotoxin and fetal hemoglobin, specifically a heme-free derivative or the γ-chain thereof. It has been discovered that the combination of endotoxin and fetal hemoglobin exhibits a pronounced synergistic biomedical activity, which is not solely based on the classical function of hemoglobin as an oxygen transporter.
Career Highlights
Throughout his career, Alfred Hartman has focused on the biomedical effects of fetal hemoglobin and its partial structures. His research has revealed that these components can modulate endotoxin-mediated bioactivity. The applications of his invention are diverse, targeting the stimulation of the immune system and addressing various health conditions, including allergic reactions, malignancies, chronic infections, autoimmune phenomena, and age-related imbalances.
Collaborations
Alfred Hartman has worked alongside notable colleagues, including Otto Westphal and Josette Westphal, who serves as a legal representative. Their collaboration has contributed to the advancement of his innovative research and patent development.
Conclusion
Alfred Hartman's work exemplifies the intersection of innovation and healthcare, showcasing how his patented compositions can potentially transform treatment approaches for various medical conditions. His contributions to the field of immunomodulation highlight the importance of continued research and development in pharmaceuticals.